Tardive Dyskinesia (TD) Treatment Drugs Market: Global Market Share, Industry Si
Posted by akshayparmar on September 12th, 2018
According to the latest market report published by Credence Research, Inc. “Tardive Dyskinesia (TD) Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018 - 2026” the global tardive dyskinesia (TD) treatment drugs market, expanding at a CAGR of 3.7% from 2018 to 2026. [Continue Readng]
Tardive dyskinesia (TD) treatment drugs market is expected to show significant market growth over the forecast period due to increase in incidence of TD, rising number of antipsychotic prescriptions, developing healthcare infrastructure and presence of late stage pipeline molecule. The global TD treatment drugs market is categorized on the basis of drug type such as valbenazine, deutetrabenazine and others (benzodiazepines, botulinum toxin, vitamin E, amantadine, levodopa, reserpine, dopamine-depleting agents and calcium channel blockers etc.). It is observed that the demand for valbenazine and deutetrabenazine is highest in market due to the efficacy and target specificity. Valbenazine and deutetrabenazine were approved in 2017. Furthermore, being the only approved drugs in the market, these drugs will experience significant demand.
Neurocrine Biosciences announced that the recently approved, Ingrezza (valbenazine) achieved .8 million net sales in third quarter in 2017. Expected launch of pipeline drug such as SNC-102 (Synchroneuron) would further drive the market growth during forecast period. Currently, North America leads the global TD treatment drugs market due to higher cost of therapeutics, early diagnosis of the disease and increase in prevalence of TD. It is predicted that TD treatment drugs market in Asia Pacific will grow significantly in coming years due to growing number of affected population and emerging healthcare infrastructure. [ContinueReading]
Market Competition Assessment:
Currently, only two drugs Valbenazine by Neurocrine Biosciences, Inc. and Deutetrabenazine by Teva Pharmaceutical Industries Ltd. are approved by US-FDA for the treatment of TD. Key players involved in R&D activities are Synchroneuron Inc. (SNC-102) and Auspex Pharmaceuticals (SD–809).
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
Credence Research Inc.
105 N 1st ST #429
About the Authorakshayparmar
Joined: July 31st, 2017
Articles Posted: 1,226
BitKong: Fairest and most thrilling Bitcoin casino on the market
Win serious funds fast when you stack the BitKong bonus combo, cash in on the referral program, or hit the massive jackpot then walk away with your life changed.
Share Your Internet Connection & Get Paid
HoneyGain is compatible for desktop computers, Android and iOS and pays you when you share your internet connection!
Claim 1 FREE Stock! No Purchase Necessary!
You have a 100% chance of receiving one free stock! Click to claim and have a chance to get one share of Facebook, Visa, Microsoft and others for free!
Passive Income - Effortlessly | Honeygain
Honeygain is the first-ever app that allows users to make money online by sharing their internet connection.
Earn Crypto with the COIN App!
Earn crypto on your Android or iOS Smartphone! Signup through this link and receive 1,000 free coins!
KuCoin | Cryptocurrency Exchange | Buy & Sell Bitcoin, Ethereum, and more
KuCoin is the most advanced and secure cryptocurrency exchange to buy and sell Bitcoin, Ethereum, Litecoin, TRON, USDT, NEO, XRP, KCS, and more. KuCoin also provide Excellent Support, Maker & Taker Transaction Fees, Open API